Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein
- 1 December 2003
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 92 (12), 1414-1418
- https://doi.org/10.1016/j.amjcard.2003.08.048
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary HypercholesterolemiaCirculation, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- Ezetimibe: efficacy and safety in clinical trialsEuropean Heart Journal Supplements, 2002
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular EventsNew England Journal of Medicine, 2002
- Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in HumansCirculation, 2002
- Simvastatin Lowers C-Reactive Protein Within 14 DaysCirculation, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic functionBritish Journal of Pharmacology, 2001
- Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol LevelsCirculation, 1998
- Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatmentEuropean Heart Journal, 1996